Participants were randomly assigned either to escalation of dulaglutide to 4.5 mg or maximum tolerated dose (MTD), or to ...

Gov. Glenn Youngkin saved about $7 million in state funds and $40 million in federal funds by vetoing a lower body-mass index ...

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

Available by prescription (Xenical) and over the counter (Alli), it is often used with a low-fat diet. While effective, ...

Tirzepatide was associated with significant reductions in weight primarily due to fat mass loss while preserving lean mass in obesity.

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

Physicians describe common prior authorization challenges when treating patients for obesity and share strategies to overcome ...

randomised to receive tirzepatide (5, 10, or 15 mg) who were treatment adherent (at least 75% doses received), all of whom initially had either obesity (body mass index, or BMI, of greater than ...

Tirzepatide works by mimicking the glucagon ... current smoker status, and BMI. The analysis identified three patterns of weight-loss trajectories: participants in Group 1 (248) experienced ...

“Our long-term analysis of tirzepatide establishes that clinically relevant weight loss can be sustained for up to three years,” Dr. Busetto noted. He added, “Regardless of age ...

TOPPING the scales at 16 stone, Joann Burland knew something had to change. At 5ft 2in and a size 20, the 49-year-old from ...